YD Bio Limited Ordinary Shares
YDES$12.38 +1.04 (9.22%)
Company News
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
YD Bio Limited plans to establish a new U.S. operations center in California to accelerate clinical development, regulatory engagement, and commercial access for cancer diagnostics and exosome-based therapeutics.


